T 1938/09 (TRANSDERMAL DELIVERY OF BUPRENORPHINE / EURO-CELTIQUE) of 09.03.2015

European Case Law Identifier: ECLI:EP:BA:2015:T193809.20150309
Date of decision: 9 March 2015
Case number: T 1938/09
Petition for review of: -
Application number: 98906678.2
IPC class: A61K 9/70 A61K 31/485 A61F 13/00
Language of proceedings: English
Distribution: Distributed to board chairmen (C)
Download: Decision in English
OJ versions: No OJ links found
Other decisions for this case: T 1938/09 Objection for suspicion of partiality 2014-10-02
Abstracts for this decision: -
Application title: SUSTAINED ANALGESIA ACHIEVED WITH TRANSDERMAL DELIVERY OF BUPRENORPHINE
Applicant name: EURO-CELTIQUE S.A.
Opponent name: Hexal AG
Acino AG
Board: 3.3.02
Headnote: -
Relevant legal provisions: Basic proposal for the revision of the EPC MR/2/00European Patent Convention Art 112a(2)(c)European Patent Convention Art 112a(3)European Patent Convention Art 114(2)European Patent Convention Art 116(4)European Patent Convention Art 123(2)European Patent Convention Art 24 European Patent Convention Art 54(2)Rules of procedure of the Boards of Appeal Art 13Rules of procedure of the Boards of Appeal Art 15(2)Rules of procedure of the Boards of Appeal Art 3(2)
Keywords: Admissibility of objection of partiality (yes) - No delay and sufficient substantiation
Admissibility of auxiliary requests (yes) - Bona fide attemps to remedy newly raised deficiencies
Admissibility of auxiliary requests (no) - Not clearly allowable and raising complex problems at late stage
Postponement of oral proceedings because of pending petition for review of a decision rejecting an objection based on suspected partiality (no) - No suspensive effect
Referral of questions to the Enlarged Board of Appeal (no)
Amendments - extension beyond the content of the application as filed (yes)
Claims - clarity after amendment (no)
Catchword: -
Cited cases: G 0002/04 R 0012/09 R 0017/09 R 0019/12
Citing cases: R 0016/22

Order

For these reasons it is decided that:

The appeal is dismissed.